Philip W Ingham Selected Research

Philip W Ingham Research Topics

6	Inflammation (Inflammations) 01/2016 - 12/2006
4	Neoplasms (Cancer) 11/2018 - 07/2004
2	Ciliopathies 08/2018 - 01/2018
2	Muscular Diseases (Myopathy) 01/2017 - 04/2008
1	Wounds and Injuries (Trauma) 05/2022
1	Cicatrix (Scar) 05/2022
1	Infections 01/2021
1	Agenesis of Cerebellar Vermis 01/2018
1	Chemical and Drug Induced Liver Injury 01/2017
1	Obesity 03/2016
1	Mitochondrial Diseases (Mitochondrial Disease) 12/2013
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 06/2013
1	Epilepsy (Aura) 11/2012
1	Seizures (Absence Seizure) 11/2012
1	Hypoxia (Hypoxemia) 07/2011
1	Thrombosis (Thrombus) 05/2008
1	Cardiomyopathies (Cardiomyopathy) 05/2008
1	Congenital Abnormalities (Deformity) 07/2004

2	Green Fluorescent ProteinsIBA 01/2021 - 12/2007
2	theasinensin AIBA 01/2021 - 02/2010
2	Proteins (Proteins, Gene)FDA Link 08/2018 - 01/2018
2	Pharmaceutical PreparationsIBA 02/2010 - 05/2008
1	Complement System Proteins (Complement)IBA 05/2022
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2021
1	Red Fluorescent ProteinIBA 01/2021
1	UbiquitinIBA 01/2021
1	Muramidase (Lysozyme)IBA 01/2021
1	Retinaldehyde (Retinal)IBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	Myosins (Myosin)IBA 01/2017
1	SOXD Transcription FactorsIBA 03/2016
1	isopimpinellinIBA 01/2016
1	Caspase 3 (Caspase-3)IBA 01/2016
1	serum-glucocorticoid regulated kinaseIBA 02/2014
1	Phosphotransferases (Kinase)IBA 12/2013
1	DNA (Deoxyribonucleic Acid)IBA 06/2013
1	ConvulsantsIBA 11/2012
1	Anticonvulsants (Antiepileptic Drugs)IBA 11/2012
1	Transcription Factors (Transcription Factor)IBA 07/2011
1	Oxygen (Dioxygen)IBA 07/2011
1	Caspase InhibitorsIBA 02/2010
1	BucladesineIBA 02/2010
1	CollagenIBA 04/2008
1	Peroxidase (Myeloperoxidase)IBA 12/2007
1	benzyloxycarbonyl-valyl-aspartic acid fluoromethyl ketoneIBA 12/2006
1	Glycoproteins (Glycoprotein)IBA 07/2004
1	LipidsIBA 07/2004

2	Therapeutics 11/2018 - 04/2013